Treceți offline cu aplicația Player FM !
Podcasturi care merită ascultate
SPONSORIZAT
![Lipstick on the Rim podcast artwork](https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/32.jpg 32w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/64.jpg 64w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/128.jpg 128w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/256.jpg 256w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/512.jpg 512w)
![Lipstick on the Rim podcast artwork](/static/images/64pixel.png)
1 Amy Schumer & Brianne Howey on the Importance of Female Friendships, Navigating Hollywood's Double Standards, Sharing Their Birth Stories, and MORE 50:05
02_01 An Overview of Considerations for Early Breast Cancer
Manage episode 342326715 series 3335024
1. History of surgery and radiation for breast cancer
2. Indication and goal of adjuvant systemic therapy (incl cell-kill hypothesis)
3. Overview of breast cancer subtypes
4. Strategies and guidelines for surveillance
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations at your region of training.
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references recommended to read related to this specific episode:
1. Bonadonna G, et al. N Engl J Med. 1976;294(8):405-410. doi:10.1056/NEJM197602192940801
2. Giuliano AE, et al. JAMA. 2017;318(10):918-926. doi:10.1001/JAMA.2017.11470
3. Abe O et al. Lancet. 2005;365(9472):1687-1717. doi:10.1016/S0140-6736(05)66544-0
4. Albain K et al. The Lancet. 2012;379(9814):432-444. doi:10.1016/S0140-6736(11)61625-5
5. Asselain B et al. Lancet Oncol. 2018;19(1):27-39. doi:10.1016/S1470-2045(17)30777-5
6. Predict Breast. Accessed September 25, 2022. https://breast.predict.nhs.uk/
7. Masuda N et al. NEJM. 2017;376(22):2147-2159. doi:10.1056/NEJMOA1612645
8. Berruti A et al J Clin Oncol. 2014;32(34):3883-3891. doi:10.1200/JCO.2014.55.2836
9. von Minckwitz G et al. J Clin Oncol. 2012;30(15):1796-1804. doi:10.1200/JCO.2011.38.8595
10. Henry NL et al. J Clin Oncol. 2019;37(22):1965-1977. doi:10.1200/JCO.19.00948
11. von Minckwitz G et al. NEJM. 2019;380(7):617-628. doi:10.1056/NEJMOA1814017/
12. Mukherjee Siddhartha. The emperor of all maladies : a biography of cancer. Published 2010.
13. Harris LN et al. J Clin Oncol. 2016;34(10):1134-1150. doi:10.1200/JCO.2015.65.2289
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
Tags
Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
49 episoade
02_01 An Overview of Considerations for Early Breast Cancer
Talking About Tumors with Ryann and Ryan - A medical oncology podcast
Manage episode 342326715 series 3335024
1. History of surgery and radiation for breast cancer
2. Indication and goal of adjuvant systemic therapy (incl cell-kill hypothesis)
3. Overview of breast cancer subtypes
4. Strategies and guidelines for surveillance
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations at your region of training.
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references recommended to read related to this specific episode:
1. Bonadonna G, et al. N Engl J Med. 1976;294(8):405-410. doi:10.1056/NEJM197602192940801
2. Giuliano AE, et al. JAMA. 2017;318(10):918-926. doi:10.1001/JAMA.2017.11470
3. Abe O et al. Lancet. 2005;365(9472):1687-1717. doi:10.1016/S0140-6736(05)66544-0
4. Albain K et al. The Lancet. 2012;379(9814):432-444. doi:10.1016/S0140-6736(11)61625-5
5. Asselain B et al. Lancet Oncol. 2018;19(1):27-39. doi:10.1016/S1470-2045(17)30777-5
6. Predict Breast. Accessed September 25, 2022. https://breast.predict.nhs.uk/
7. Masuda N et al. NEJM. 2017;376(22):2147-2159. doi:10.1056/NEJMOA1612645
8. Berruti A et al J Clin Oncol. 2014;32(34):3883-3891. doi:10.1200/JCO.2014.55.2836
9. von Minckwitz G et al. J Clin Oncol. 2012;30(15):1796-1804. doi:10.1200/JCO.2011.38.8595
10. Henry NL et al. J Clin Oncol. 2019;37(22):1965-1977. doi:10.1200/JCO.19.00948
11. von Minckwitz G et al. NEJM. 2019;380(7):617-628. doi:10.1056/NEJMOA1814017/
12. Mukherjee Siddhartha. The emperor of all maladies : a biography of cancer. Published 2010.
13. Harris LN et al. J Clin Oncol. 2016;34(10):1134-1150. doi:10.1200/JCO.2015.65.2289
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
Tags
Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
49 episoade
Tous les épisodes
×![Artwork](/static/images/128pixel.png)
1 05_01 Hepatocellular carcinoma 32:13
![Artwork](/static/images/128pixel.png)
1 04_08 Metastatic Renal Cell Carcinoma 24:16
![Artwork](/static/images/128pixel.png)
1 04_07 Localized Renal Cell Carcinoma 25:15
![Artwork](/static/images/128pixel.png)
1 04_06 Metastatic Urothelial Cancer 24:33
![Artwork](/static/images/128pixel.png)
1 04_05 Muscle Invasive Bladder Cancer 29:16
![Artwork](/static/images/128pixel.png)
1 01_14 Ampullary Carcinoma (Mini Discussion) 10:59
![Artwork](/static/images/128pixel.png)
1 04_04 Castrate Resistant Metastatic Prostate Cancer 24:50
![Artwork](/static/images/128pixel.png)
1 04_03 Metastatic Castrate Sensitive Prostate Cancer 29:02
![Artwork](/static/images/128pixel.png)
1 04_02 Adjuvant Options for Prostate Cancer 28:41
![Artwork](/static/images/128pixel.png)
1 04_01 Fundamentals of Localized Prostate Cancer 31:59
![Artwork](/static/images/128pixel.png)
1 03_13 Head and Neck Cancer – Locally advanced and metastatic 37:18
![Artwork](/static/images/128pixel.png)
1 03_12 Head and Neck Cancer – Background and adjuvant considerations 23:28
![Artwork](/static/images/128pixel.png)
1 03_11 Mesothelioma and a bit of Large Cell Neuroendocrine Carcinoma 29:40
![Artwork](/static/images/128pixel.png)
1 03_10 Small cell lung cancer 33:31
![Artwork](/static/images/128pixel.png)
1 03_09 Stage III NSCLC for the Medical Oncologist 27:46
![Artwork](/static/images/128pixel.png)
1 03_06 Driver Mutations in Advanced NSCLC 34:06
![Artwork](/static/images/128pixel.png)
1 03_05 NSCLC metastatic without driver mutations 31:52
![Artwork](/static/images/128pixel.png)
1 03_04 Overview of Lung Cancer 25:14
![Artwork](/static/images/128pixel.png)
1 03_01 The era of immune checkpoint inhibitors 22:59
![Artwork](/static/images/128pixel.png)
1 02_10 BRCA Positive Breast Cancer in the Clinic 21:39
![Artwork](/static/images/128pixel.png)
1 02_09 Triple Negative Breast Cancer 27:07
![Artwork](/static/images/128pixel.png)
1 02_08 Early HER-2 positive breast cancer 25:27
![Artwork](/static/images/128pixel.png)
1 02_07 HER-2 positive breast cancer: Considerations in advanced disease 25:12
![Artwork](/static/images/128pixel.png)
1 02_06 HER-2 Low Breast Cancer and Sacutuzumab Govetecan 22:30
Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.